FR2293931B1 - - Google Patents

Info

Publication number
FR2293931B1
FR2293931B1 FR7440233A FR7440233A FR2293931B1 FR 2293931 B1 FR2293931 B1 FR 2293931B1 FR 7440233 A FR7440233 A FR 7440233A FR 7440233 A FR7440233 A FR 7440233A FR 2293931 B1 FR2293931 B1 FR 2293931B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7440233A
Other languages
French (fr)
Other versions
FR2293931A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7440233A priority Critical patent/FR2293931A1/fr
Priority to IL48508A priority patent/IL48508A/xx
Priority to ES442910A priority patent/ES442910A1/es
Priority to DE2552869A priority patent/DE2552869C2/de
Priority to ZA7444A priority patent/ZA757444B/xx
Priority to SE7513391A priority patent/SE408422B/xx
Priority to US05/636,098 priority patent/US3993764A/en
Priority to GB2344/78A priority patent/GB1529330A/en
Priority to CA240,857A priority patent/CA1089766A/fr
Priority to GB49210/75A priority patent/GB1529329A/en
Priority to AU87173/75A priority patent/AU498955B2/en
Priority to MX004196U priority patent/MX3046E/es
Priority to BE162540A priority patent/BE836391A/xx
Priority to JP50145182A priority patent/JPS5186475A/ja
Priority to CH1594675A priority patent/CH605915A5/xx
Priority to NL7514255A priority patent/NL7514255A/xx
Priority to DK553175AA priority patent/DK139580B/da
Priority to LU73947A priority patent/LU73947A1/xx
Priority to IE2675/75A priority patent/IE42618B1/en
Publication of FR2293931A1 publication Critical patent/FR2293931A1/fr
Application granted granted Critical
Publication of FR2293931B1 publication Critical patent/FR2293931B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FR7440233A 1974-12-09 1974-12-09 Application a titre de medicaments de derives du piperidyl-indole Granted FR2293931A1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR7440233A FR2293931A1 (fr) 1974-12-09 1974-12-09 Application a titre de medicaments de derives du piperidyl-indole
IL48508A IL48508A (en) 1974-12-09 1975-11-20 Pharmaceutical compositions comprising piperidylindole derivatives
ES442910A ES442910A1 (es) 1974-12-09 1975-11-24 Procedimiento de preparacion de sales de adicion con acidos minerales u organicos de derivados de piperidil-indol
DE2552869A DE2552869C2 (de) 1974-12-09 1975-11-25 Pharmazeutische Zusammensetzungen mit Piperidylindol-Derivaten
ZA7444A ZA757444B (en) 1974-12-09 1975-11-26 A pharmaceutical composition containing at least one piperidyl-indole
SE7513391A SE408422B (sv) 1974-12-09 1975-11-27 Analogiforfarande for framstellning av salter av piperidyl-indolderivat
US05/636,098 US3993764A (en) 1974-12-09 1975-11-28 Treatment of depressive states and Parkinson's disease
CA240,857A CA1089766A (fr) 1974-12-09 1975-12-01 Application comme medicaments de derives du piperidyl- indole
GB49210/75A GB1529329A (en) 1974-12-09 1975-12-01 Pharmaceutical compositions containing piperidylindole derivatives
GB2344/78A GB1529330A (en) 1974-12-09 1975-12-01 Acid addition salts of 3-(4'-piperidyl)-indole derivative
AU87173/75A AU498955B2 (en) 1974-12-09 1975-12-02 3-(4'-piperidyl) indoles
MX004196U MX3046E (es) 1974-12-09 1975-12-02 Procedimiento de preparacion de sales de adicion de derivados del piperidil - indol
BE162540A BE836391A (fr) 1974-12-09 1975-12-08 Nouvelles compositions pharmaceutiques renfermant un derive du piperidyl indole ou l'un de ses sels
JP50145182A JPS5186475A (es) 1974-12-09 1975-12-08
CH1594675A CH605915A5 (es) 1974-12-09 1975-12-08
NL7514255A NL7514255A (nl) 1974-12-09 1975-12-08 Werkwijze voor de bereiding van piperidylindolen en farmaceutische preparaten die ze bevatten.
DK553175AA DK139580B (da) 1974-12-09 1975-12-08 Analogifremgangsmåde til fremstilling af additionssalte af piperidylindolderivater.
LU73947A LU73947A1 (es) 1974-12-09 1975-12-08
IE2675/75A IE42618B1 (en) 1974-12-09 1975-12-09 New pharmaceutical compositions containing piperidyl-indole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7440233A FR2293931A1 (fr) 1974-12-09 1974-12-09 Application a titre de medicaments de derives du piperidyl-indole

Publications (2)

Publication Number Publication Date
FR2293931A1 FR2293931A1 (fr) 1976-07-09
FR2293931B1 true FR2293931B1 (es) 1978-07-21

Family

ID=9145754

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7440233A Granted FR2293931A1 (fr) 1974-12-09 1974-12-09 Application a titre de medicaments de derives du piperidyl-indole

Country Status (3)

Country Link
BE (1) BE836391A (es)
FR (1) FR2293931A1 (es)
ZA (1) ZA757444B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426465B1 (es) * 1978-01-16 1983-04-29 Roussel Uclaf

Also Published As

Publication number Publication date
FR2293931A1 (fr) 1976-07-09
BE836391A (fr) 1976-06-08
ZA757444B (en) 1977-01-26

Similar Documents

Publication Publication Date Title
FR2265782B1 (es)
FR2271299B1 (es)
IN142428B (es)
FR2271617B1 (es)
FR2264601A1 (es)
JPS50102082A (es)
FR2284800B1 (es)
FR2294006B1 (es)
FR2267842A1 (es)
FR2271110B1 (es)
FR2268182B3 (es)
FR2285460B1 (es)
JPS50102386A (es)
DK16475A (es)
JPS50104414U (es)
FR2283938B1 (es)
IN144414B (es)
JPS50103242A (es)
CH568134A5 (es)
CH1727074A4 (es)
CH591152A5 (es)
CH569666A5 (es)
CH569220A5 (es)
CH568539A5 (es)
DD122825A5 (es)

Legal Events

Date Code Title Description
ST Notification of lapse